BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li G, Suzuki H, Asano T, Tanaka T, Suzuki H, Kaneko MK, Kato Y. Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications. Antibodies (Basel) 2022;11:41. [PMID: 35735360 DOI: 10.3390/antib11020041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li G, Suzuki H, Ohishi T, Asano T, Tanaka T, Yanaka M, Nakamura T, Yoshikawa T, Kawada M, Kaneko MK, Kato Y. Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models. Int J Mol Med 2023;51:18. [PMID: 36660940 DOI: 10.3892/ijmm.2023.5221] [Reference Citation Analysis]
2 Tanaka T, Suzuki H, Isoda Y, Asano T, Nakamura T, Yanaka M, Handa S, Takahashi N, Okuno S, Yoshikawa T, Li G, Nanamiya R, Goto N, Tateyama N, Okada Y, Kobayashi H, Kaneko MK, Kato Y. Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C(9)Mab-11) by N-Terminal Peptide Immunization. Monoclon Antib Immunodiagn Immunother 2022;41:303-10. [PMID: 36383113 DOI: 10.1089/mab.2022.0027] [Reference Citation Analysis]
3 Carcelen M, Vidal V, Franco A, Gomez M, Moreno F, Fernandez-luna JL. Plasmonic Biosensing for Label-Free Detection of Two Hallmarks of Cancer Cells: Cell-Matrix Interaction and Cell Division. Biosensors 2022;12:674. [DOI: 10.3390/bios12090674] [Reference Citation Analysis]
4 Ward K, Kitchen MO, Mathias SJ, Khanim FL, Bryan RT. Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning. Front Surg 2022;9:912438. [PMID: 35959122 DOI: 10.3389/fsurg.2022.912438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]